Search Legislation

Commission Implementing Regulation (EU) 2020/484Show full title

Commission Implementing Regulation (EU) 2020/484 of 2 April 2020 authorising the placing on the market of lacto-N-tetraose as a novel food under Regulation (EU) 2015/2283 of the European Parliament and of the Council and amending Commission Implementing Regulation (EU) 2017/2470 (Text with EEA relevance)

 Help about what version

What Version

 Help about UK-EU Regulation

Legislation originating from the EU

When the UK left the EU, legislation.gov.uk published EU legislation that had been published by the EU up to IP completion day (31 December 2020 11.00 p.m.). On legislation.gov.uk, these items of legislation are kept up-to-date with any amendments made by the UK since then.

Close

This item of legislation originated from the EU

Legislation.gov.uk publishes the UK version. EUR-Lex publishes the EU version. The EU Exit Web Archive holds a snapshot of EUR-Lex’s version from IP completion day (31 December 2020 11.00 p.m.).

Status:

This is the original version as it was originally adopted in the EU.
This legislation may since have been updated - see the latest available (revised) version

ANNEX

The Annex to Implementing Regulation (EU) 2017/2470 is amended as follows:

(1)

in Table 1 (Authorised novel foods), the following entry is inserted in alphabetical order:

Authorised novel foodConditions under which the novel food may be usedAdditional specific labelling requirementsOther requirementsData Protection

‘Lacto-N-tetraose (“LNT”)

(microbial source)

Specified food category Maximum levels

The designation of the novel food on the labelling of the foodstuffs containing it shall be “lacto-N-tetraose”.

The labelling of food supplements containing lacto-N-tetraose shall bear a statement that they should not be used if breast milk or other foods containing added lacto-N-tetraose are consumed the same day.

Authorised on 23.4.2020. This inclusion is based on proprietary scientific evidence and scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283.

Applicant: Glycom A/S, Kogle Allé 4, DK-2970 Hørsholm, Denmark. During the period of data protection, the novel food lacto-N-tetraose is authorised for placing on the market within the Union only by Glycom A/S, unless a subsequent applicant obtains authorisation for the novel food without reference to the proprietary scientific evidence or scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283 or with the agreement of Glycom A/S.

End date of the data protection: 23.4.2025.’

Unflavoured pasteurised and unflavoured sterilised (including UHT) milk products1,0 g/l
Unflavoured fermented milk-based products

1,0 g/l (beverages)

10 g/kg (products other than beverages)

Flavoured fermented milk-based products including heat-treated products

1,0 g/l (beverages)

10 g/kg (products other than beverages)

Beverages (flavoured drinks)1,0 g/l
Cereal bars10 g/kg
Infant formula as defined under Regulation (EU) No 609/20130,8 g/l in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer
Follow-on formula as defined under Regulation (EU) No 609/20130,6 g/l in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer
Processed cereal-based food, baby food for infants and young children as defined under Regulation (EU) No 609/2013

0,6 g/l (beverages) in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer

5 g/kg for products other than beverages

Milk based drinks and similar products intended for young children

0,6 g/l (beverages) in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer

5 g/kg for products other than beverages

Total diet replacement foods for weight control as defined under Regulation (EU) No 609/2013

2,0 g/l (beverages)

20 g/kg (products other than beverages)

Food for special medical purposes as defined under Regulation (EU) No 609/2013In accordance with the particular nutritional requirements of the persons for whom the products are intended
Food Supplements as defined in Directive 2002/46/EC, excluding infants2,0 g/day for young children, children, adolescents, and adults
(2)

in Table 2 (Specifications), the following entry is inserted in alphabetical order:

CFU: Colony Forming Units; EU: Endotoxin Units.’
Authorised Novel FoodSpecification

‘Lacto-N-tetraose (“LNT”)

(microbial source)

Definition:

Chemical formula: C26H45O21

Chemical name: β-D-Galactopyranosyl-(1→3)-2-acetamido-2-deoxy-β-D-glucopyranosyl-(1→3)-β-D-galactopyranosyl-(1→4)-D-glucopyranose

Molecular mass: 707,63 Da

CAS No 14116-68-8

Description:

Lacto-N-tetraose is a purified, white to off-white amorphous powder that is produced by a microbial process.

Source: Genetically modified strain of Escherichia coli strain K-12 DH1

Characteristics/Composition:

Appearance: White to off-white powder

Sum of lacto-N-tetraose, D-Lactose and lacto-N-tetraose II (% of dry matter): ≥ 90,0 % (w/w)

Lacto-N-tetraose (% of dry matter): ≥ 70,0 % (w/w)

D-Lactose: ≤ 12,0 % (w/w)

Lacto-N-tetraose II: ≤ 10,0 % (w/w)

Para-lacto-N-hexaose-2: ≤ 3,5 % (w/w)

Lacto-N-tetraose fructose isomer: ≤ 1,0 % (w/w)

Sum of other carbohydrates: ≤ 5,0 % (w/w)

Moisture: ≤ 6,0 % (w/w)

Ash, sulfated: ≤ 0,5 % (w/w)

pH (20 °C, 5 % solution): 4,0–6,0

Residual protein: ≤ 0,01 % (w/w)

Microbiological criteria:

Aerobic mesophilic bacteria total plate count: ≤ 1 000 CFU/g

Enterobacteriaceae: ≤ 10 CFU/g

Salmonella sp.: Negative/25 g

Yeast: ≤ 100 CFU/g

Mould: ≤ 100 CFU/g

Residual endotoxins: ≤ 10 EU/mg

Back to top

Options/Help

Print Options

Close

Legislation is available in different versions:

Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.

Original (As adopted by EU): The original version of the legislation as it stood when it was first adopted in the EU. No changes have been applied to the text.

Close

Opening Options

Different options to open legislation in order to view more content on screen at once

Close

More Resources

Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:

  • the original print PDF of the as adopted version that was used for the EU Official Journal
  • lists of changes made by and/or affecting this legislation item
  • all formats of all associated documents
  • correction slips
  • links to related legislation and further information resources
Close

More Resources

Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:

  • the original print PDF of the as adopted version that was used for the print copy
  • correction slips

Click 'View More' or select 'More Resources' tab for additional information including:

  • lists of changes made by and/or affecting this legislation item
  • confers power and blanket amendment details
  • all formats of all associated documents
  • links to related legislation and further information resources